Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Medivir AB
MVIRCurrent price
2.88 SEK
+0.08 SEK (+2.86%)
Last closed
2.8 SEK
Company
–
ISIN
SE0000273294
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
317 229 848 SEK
Yield for 12 month
-21.42 %
1Y
3Y
5Y
10Y
15Y
MVIR
Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It is also developing Remetinostat for treating MF cutaneous T-cell lymphoma and basal cell carcinoma, as well as squamous cell carcinoma. In addition, the company is developing MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors, as well as USP-1/TNG348, USP-7, and MBLI/MET-X, which completed preclinical trials for treating cancer and infection. It has a clinical trial collaboration and supply agreement with Eisai to evaluate fostrox, a liver-targeted treatment, in combination with lenvatinib for the treatment of liver cancer. The company was incorporated in 1987 and is based in Huddinge, Sweden. Address: Lunastigen 5, Huddinge, Sweden
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
263.85 SEKP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures MVIR
1 year
3 years
5 years
10 years
EBITDA
-121 599 682 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-39.89 %
PEG Ratio
–
Return On Equity TTM
-87.81 %
Wall Street Target Price
263.85 SEK
Revenue TTM
7 550 553 SEK
Book Value
1.24 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
50 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.22 SEK
Diluted Eps TTM
-1.22 SEK
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics MVIR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MVIR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
09.05.1996
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation MVIR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
23.487
Price Sales TTM
42.0141
Enterprise Value EBITDA
-2.9397
Price Book MRQ
1.7845
Financials MVIR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MVIR
For 52 weeks
2.34 SEK
5.51 SEK
50 Day MA
2.99 SEK
Shares Short Prior Month
–
200 Day MA
2.98 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart